APO Research

APO RESEARCH · REPORT

Antihelminthics

Selected research

Market Analysis & Forecast

Global Antihelminthics Market Analysis and Forecast 2026-2032

Market perspective

The global Antihelminthics market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Antihelminthics is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Antihelminthics is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Antihelminthics is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Antihelminthics is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Antihelminthics include Abbott, Sanofi, Sanofi, Johnson & Johnson, Novartis, Pfizer, GlaxoSmithKline, Bayer and AstraZeneca, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Antihelminthics, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Antihelminthics, also provides the sales of main regions and countries. Of the upcoming market potential for Antihelminthics, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Antihelminthics sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Antihelminthics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Antihelminthics sales, projected growth trends, production technology, application and end-user industry.

Antihelminthics Segment by Company

Abbott

Sanofi

Sanofi

Johnson & Johnson

Novartis

Pfizer

GlaxoSmithKline

Bayer

AstraZeneca

ZEISS International

Merck & Co.

Mentis Pharma

Astellas Pharma

ALLERGAN

Antihelminthics Segment by Type

Salicylanilides

Benzimidazoles

Praziquantel

Abamectin

Other

Antihelminthics Segment by Application

Ascariasis

Giardiasis

Fasciolasis

Filariasis

Angiostrongylosis

Schistosomiasis

Other

Antihelminthics Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Antihelminthics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Antihelminthics and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Antihelminthics.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Antihelminthics in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Antihelminthics manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Antihelminthics sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Antihelminthics Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Salicylanilides Major Manufacturers Table 3. Benzimidazoles Major Manufacturers Table 4. Praziquantel Major Manufacturers Table 5. Abamectin Major Manufacturers Table 6. Other Major Manufacturers Table 7. Global Antihelminthics Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 8. Ascariasis Major Manufacturers Table 9. Giardiasis Major Manufacturers Table 10. Fasciolasis Major Manufacturers Table 11. Filariasis Major Manufacturers Table 12. Angiostrongylosis Major Manufacturers Table 13. Schistosomiasis Major Manufacturers Table 14. Other Major Manufacturers Table 15. Antihelminthics Industry Trends Table 16. Antihelminthics Industry Drivers Table 17. Antihelminthics Industry Opportunities and Challenges Table 18. Antihelminthics Industry Restraints Table 19. Global Antihelminthics Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 20. Global Antihelminthics Revenue by Region (2021-2026) & (US$ Million) Table 21. Global Antihelminthics Revenue by Region (2027-2032) & (US$ Million) Table 22. Global Antihelminthics Revenue Market Share by Region (2021-2026) Table 23. Global Antihelminthics Revenue Market Share by Region (2027-2032) Table 24. Global Antihelminthics Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 25. Global Antihelminthics Sales by Region (2021-2026) & (K Units) Table 26. Global Antihelminthics Sales by Region (2027-2032) & (K Units) Table 27. Global Antihelminthics Sales Market Share by Region (2021-2026) Table 28. Global Antihelminthics Sales Market Share by Region (2027-2032) Table 29. Global Antihelminthics Revenue by Manufacturers (US$ Million) & (2021-2026) Table 30. Global Antihelminthics Revenue Market Share by Manufacturers (2021-2026) Table 31. Global Antihelminthics Sales by Manufacturers (US$ Million) & (2021-2026) Table 32. Global Antihelminthics Sales Market Share by Manufacturers (2021-2026) Table 33. Global Antihelminthics Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 34. Global Antihelminthics Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 35. Global Antihelminthics Key Manufacturers Manufacturing Sites & Headquarters Table 36. Global Antihelminthics Manufacturers, Product Type & Application Table 37. Global Antihelminthics Manufacturers' Establishment Date Table 38. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 39. Global Antihelminthics by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Antihelminthics Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 41. Global Antihelminthics Revenue by Type (2021-2026) & (US$ Million) Table 42. Global Antihelminthics Revenue by Type (2027-2032) & (US$ Million) Table 43. Global Antihelminthics Revenue Market Share by Type (2021-2026) Table 44. Global Antihelminthics Revenue Market Share by Type (2027-2032) Table 45. Global Antihelminthics Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 46. Global Antihelminthics Sales by Type (2021-2026) & (K Units) Table 47. Global Antihelminthics Sales by Type (2027-2032) & (K Units) Table 48. Global Antihelminthics Sales Market Share by Type (2021-2026) Table 49. Global Antihelminthics Sales Market Share by Type (2027-2032) Table 50. Global Antihelminthics Price by Type (2021-2026) & (US$/Unit) Table 51. Global Antihelminthics Price by Type (2027-2032) & (US$/Unit) Table 52. Global Antihelminthics Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 53. Global Antihelminthics Revenue by Application (2021-2026) & (US$ Million) Table 54. Global Antihelminthics Revenue by Application (2027-2032) & (US$ Million) Table 55. Global Antihelminthics Revenue Market Share by Application (2021-2026) Table 56. Global Antihelminthics Revenue Market Share by Application (2027-2032) Table 57. Global Antihelminthics Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 58. Global Antihelminthics Sales by Application (2021-2026) & (K Units) Table 59. Global Antihelminthics Sales by Application (2027-2032) & (K Units) Table 60. Global Antihelminthics Sales Market Share by Application (2021-2026) Table 61. Global Antihelminthics Sales Market Share by Application (2027-2032) Table 62. Global Antihelminthics Price by Application (2021-2026) & (US$/Unit) Table 63. Global Antihelminthics Price by Application (2027-2032) & (US$/Unit) Table 64. Abbott Company Information Table 65. Abbott Business Overview Table 66. Abbott Antihelminthics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. Abbott Antihelminthics Product Portfolio Table 68. Abbott Recent Development Table 69. Sanofi Company Information Table 70. Sanofi Business Overview Table 71. Sanofi Antihelminthics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. Sanofi Antihelminthics Product Portfolio Table 73. Sanofi Recent Development Table 74. Sanofi Company Information Table 75. Sanofi Business Overview Table 76. Sanofi Antihelminthics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Sanofi Antihelminthics Product Portfolio Table 78. Sanofi Recent Development Table 79. Johnson & Johnson Company Information Table 80. Johnson & Johnson Business Overview Table 81. Johnson & Johnson Antihelminthics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Johnson & Johnson Antihelminthics Product Portfolio Table 83. Johnson & Johnson Recent Development Table 84. Novartis Company Information Table 85. Novartis Business Overview Table 86. Novartis Antihelminthics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Novartis Antihelminthics Product Portfolio Table 88. Novartis Recent Development Table 89. Pfizer Company Information Table 90. Pfizer Business Overview Table 91. Pfizer Antihelminthics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Pfizer Antihelminthics Product Portfolio Table 93. Pfizer Recent Development Table 94. GlaxoSmithKline Company Information Table 95. GlaxoSmithKline Business Overview Table 96. GlaxoSmithKline Antihelminthics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. GlaxoSmithKline Antihelminthics Product Portfolio Table 98. GlaxoSmithKline Recent Development Table 99. Bayer Company Information Table 100. Bayer Business Overview Table 101. Bayer Antihelminthics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Bayer Antihelminthics Product Portfolio Table 103. Bayer Recent Development Table 104. AstraZeneca Company Information Table 105. AstraZeneca Business Overview Table 106. AstraZeneca Antihelminthics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. AstraZeneca Antihelminthics Product Portfolio Table 108. AstraZeneca Recent Development Table 109. ZEISS International Company Information Table 110. ZEISS International Business Overview Table 111. ZEISS International Antihelminthics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 112. ZEISS International Antihelminthics Product Portfolio Table 113. ZEISS International Recent Development Table 114. Merck & Co. Company Information Table 115. Merck & Co. Business Overview Table 116. Merck & Co. Antihelminthics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 117. Merck & Co. Antihelminthics Product Portfolio Table 118. Merck & Co. Recent Development Table 119. Mentis Pharma Company Information Table 120. Mentis Pharma Business Overview Table 121. Mentis Pharma Antihelminthics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 122. Mentis Pharma Antihelminthics Product Portfolio Table 123. Mentis Pharma Recent Development Table 124. Astellas Pharma Company Information Table 125. Astellas Pharma Business Overview Table 126. Astellas Pharma Antihelminthics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 127. Astellas Pharma Antihelminthics Product Portfolio Table 128. Astellas Pharma Recent Development Table 129. ALLERGAN Company Information Table 130. ALLERGAN Business Overview Table 131. ALLERGAN Antihelminthics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 132. ALLERGAN Antihelminthics Product Portfolio Table 133. ALLERGAN Recent Development Table 134. North America Antihelminthics Revenue by Type (2021-2026) & (US$ Million) Table 135. North America Antihelminthics Revenue by Type (2027-2032) & (US$ Million) Table 136. North America Antihelminthics Sales by Type (2021-2026) & (K Units) Table 137. North America Antihelminthics Sales by Type (2027-2032) & (K Units) Table 138. North America Antihelminthics Sales Price by Type (2021-2026) & (US$/Unit) Table 139. North America Antihelminthics Sales Price by Type (2027-2032) & (US$/Unit) Table 140. North America Antihelminthics Revenue by Application (2021-2026) & (US$ Million) Table 141. North America Antihelminthics Revenue by Application (2027-2032) & (US$ Million) Table 142. North America Antihelminthics Sales by Application (2021-2026) & (K Units) Table 143. North America Antihelminthics Sales by Application (2027-2032) & (K Units) Table 144. North America Antihelminthics Sales Price by Application (2021-2026) & (US$/Unit) Table 145. North America Antihelminthics Sales Price by Application (2027-2032) & (US$/Unit) Table 146. North America Antihelminthics Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 147. North America Antihelminthics Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 148. North America Antihelminthics Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 149. North America Antihelminthics Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 150. North America Antihelminthics Sales by Country (2021-2026) & (K Units) Table 151. North America Antihelminthics Sales by Country (2027-2032) & (K Units) Table 152. North America Antihelminthics Sales Price by Country (2021-2026) & (US$/Unit) Table 153. North America Antihelminthics Sales Price by Country (2027-2032) & (US$/Unit) Table 154. United States Antihelminthics Revenue (2021-2032) & (US$ Million) Table 155. Canada Antihelminthics Revenue (2021-2032) & (US$ Million) Table 156. Europe Antihelminthics Revenue by Type (2021-2026) & (US$ Million) Table 157. Europe Antihelminthics Revenue by Type (2027-2032) & (US$ Million) Table 158. Europe Antihelminthics Sales by Type (2021-2026) & (K Units) Table 159. Europe Antihelminthics Sales by Type (2027-2032) & (K Units) Table 160. Europe Antihelminthics Sales Price by Type (2021-2026) & (US$/Unit) Table 161. Europe Antihelminthics Sales Price by Type (2027-2032) & (US$/Unit) Table 162. Europe Antihelminthics Revenue by Application (2021-2026) & (US$ Million) Table 163. Europe Antihelminthics Revenue by Application (2027-2032) & (US$ Million) Table 164. Europe Antihelminthics Sales by Application (2021-2026) & (K Units) Table 165. Europe Antihelminthics Sales by Application (2027-2032) & (K Units) Table 166. Europe Antihelminthics Sales Price by Application (2021-2026) & (US$/Unit) Table 167. Europe Antihelminthics Sales Price by Application (2027-2032) & (US$/Unit) Table 168. Europe Antihelminthics Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 169. Europe Antihelminthics Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 170. Europe Antihelminthics Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 171. Europe Antihelminthics Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 172. Europe Antihelminthics Sales by Country (2021-2026) & (K Units) Table 173. Europe Antihelminthics Sales by Country (2027-2032) & (K Units) Table 174. Europe Antihelminthics Sales Price by Country (2021-2026) & (US$/Unit) Table 175. Europe Antihelminthics Sales Price by Country (2027-2032) & (US$/Unit) Table 176. Germany Antihelminthics Revenue (2021-2032) & (US$ Million) Table 177. France Antihelminthics Revenue (2021-2032) & (US$ Million) Table 178. U.K. Antihelminthics Revenue (2021-2032) & (US$ Million) Table 179. Italy Antihelminthics Revenue (2021-2032) & (US$ Million) Table 180. Netherlands Antihelminthics Revenue (2021-2032) & (US$ Million) Table 181. Nordic Countries Antihelminthics Revenue (2021-2032) & (US$ Million) Table 182. China Antihelminthics Revenue by Type (2021-2026) & (US$ Million) Table 183. China Antihelminthics Revenue by Type (2027-2032) & (US$ Million) Table 184. China Antihelminthics Sales by Type (2021-2026) & (K Units) Table 185. China Antihelminthics Sales by Type (2027-2032) & (K Units) Table 186. China Antihelminthics Sales Price by Type (2021-2026) & (US$/Unit) Table 187. China Antihelminthics Sales Price by Type (2027-2032) & (US$/Unit) Table 188. China Antihelminthics Revenue by Application (2021-2026) & (US$ Million) Table 189. China Antihelminthics Revenue by Application (2027-2032) & (US$ Million) Table 190. China Antihelminthics Sales by Application (2021-2026) & (K Units) Table 191. China Antihelminthics Sales by Application (2027-2032) & (K Units) Table 192. China Antihelminthics Sales Price by Application (2021-2026) & (US$/Unit) Table 193. China Antihelminthics Sales Price by Application (2027-2032) & (US$/Unit) Table 194. Asia Antihelminthics Revenue by Type (2021-2026) & (US$ Million) Table 195. Asia Antihelminthics Revenue by Type (2027-2032) & (US$ Million) Table 196. Asia Antihelminthics Sales by Type (2021-2026) & (K Units) Table 197. Asia Antihelminthics Sales by Type (2027-2032) & (K Units) Table 198. Asia Antihelminthics Sales Price by Type (2021-2026) & (US$/Unit) Table 199. Asia Antihelminthics Sales Price by Type (2027-2032) & (US$/Unit) Table 200. Asia Antihelminthics Revenue by Application (2021-2026) & (US$ Million) Table 201. Asia Antihelminthics Revenue by Application (2027-2032) & (US$ Million) Table 202. Asia Antihelminthics Sales by Application (2021-2026) & (K Units) Table 203. Asia Antihelminthics Sales by Application (2027-2032) & (K Units) Table 204. Asia Antihelminthics Sales Price by Application (2021-2026) & (US$/Unit) Table 205. Asia Antihelminthics Sales Price by Application (2027-2032) & (US$/Unit) Table 206. Asia Antihelminthics Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 207. Asia Antihelminthics Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 208. Asia Antihelminthics Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 209. Asia Antihelminthics Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 210. Asia Antihelminthics Sales by Country (2021-2026) & (K Units) Table 211. Asia Antihelminthics Sales by Country (2027-2032) & (K Units) Table 212. Asia Antihelminthics Sales Price by Country (2021-2026) & (US$/Unit) Table 213. Asia Antihelminthics Sales Price by Country (2027-2032) & (US$/Unit) Table 214. Japan Antihelminthics Revenue (2021-2032) & (US$ Million) Table 215. South Korea Antihelminthics Revenue (2021-2032) & (US$ Million) Table 216. India Antihelminthics Revenue (2021-2032) & (US$ Million) Table 217. Australia Antihelminthics Revenue (2021-2032) & (US$ Million) Table 218. China Taiwan Antihelminthics Revenue (2021-2032) & (US$ Million) Table 219. Southeast Asia Antihelminthics Revenue (2021-2032) & (US$ Million) Table 220. SAMEA Antihelminthics Revenue by Type (2021-2026) & (US$ Million) Table 221. SAMEA Antihelminthics Revenue by Type (2027-2032) & (US$ Million) Table 222. SAMEA Antihelminthics Sales by Type (2021-2026) & (K Units) Table 223. SAMEA Antihelminthics Sales by Type (2027-2032) & (K Units) Table 224. SAMEA Antihelminthics Sales Price by Type (2021-2026) & (US$/Unit) Table 225. SAMEA Antihelminthics Sales Price by Type (2027-2032) & (US$/Unit) Table 226. SAMEA Antihelminthics Revenue by Application (2021-2026) & (US$ Million) Table 227. SAMEA Antihelminthics Revenue by Application (2027-2032) & (US$ Million) Table 228. SAMEA Antihelminthics Sales by Application (2021-2026) & (K Units) Table 229. SAMEA Antihelminthics Sales by Application (2027-2032) & (K Units) Table 230. SAMEA Antihelminthics Sales Price by Application (2021-2026) & (US$/Unit) Table 231. SAMEA Antihelminthics Sales Price by Application (2027-2032) & (US$/Unit) Table 232. SAMEA Antihelminthics Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 233. SAMEA Antihelminthics Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 234. SAMEA Antihelminthics Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 235. SAMEA Antihelminthics Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 236. SAMEA Antihelminthics Sales by Country (2021-2026) & (K Units) Table 237. SAMEA Antihelminthics Sales by Country (2027-2032) & (K Units) Table 238. SAMEA Antihelminthics Sales Price by Country (2021-2026) & (US$/Unit) Table 239. SAMEA Antihelminthics Sales Price by Country (2027-2032) & (US$/Unit) Table 240. Brazil Antihelminthics Revenue (2021-2032) & (US$ Million) Table 241. Argentina Antihelminthics Revenue (2021-2032) & (US$ Million) Table 242. Chile Antihelminthics Revenue (2021-2032) & (US$ Million) Table 243. Colombia Antihelminthics Revenue (2021-2032) & (US$ Million) Table 244. Peru Antihelminthics Revenue (2021-2032) & (US$ Million) Table 245. Saudi Arabia Antihelminthics Revenue (2021-2032) & (US$ Million) Table 246. Israel Antihelminthics Revenue (2021-2032) & (US$ Million) Table 247. UAE Antihelminthics Revenue (2021-2032) & (US$ Million) Table 248. Turkey Antihelminthics Revenue (2021-2032) & (US$ Million) Table 249. Iran Antihelminthics Revenue (2021-2032) & (US$ Million) Table 250. Egypt Antihelminthics Revenue (2021-2032) & (US$ Million) Table 251. Key Raw Materials Table 252. Raw Materials Key Suppliers Table 253. Antihelminthics Distributors List Table 254. Antihelminthics Customers List Table 255. Research Programs/Design for This Report Table 256. Authors List of This Report Table 257. Secondary Sources Table 258. Primary Sources List of Figures Figure 1. Antihelminthics Image Figure 2. Global Antihelminthics Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Antihelminthics Market Size Share 2021 VS 2025 VS 2032 Figure 4. Salicylanilides Image Figure 5. Benzimidazoles Image Figure 6. Praziquantel Image Figure 7. Abamectin Image Figure 8. Other Image Figure 9. Global Antihelminthics Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 10. Global Antihelminthics Market Size Share 2021 VS 2025 VS 2032 Figure 11. Ascariasis Image Figure 12. Giardiasis Image Figure 13. Fasciolasis Image Figure 14. Filariasis Image Figure 15. Angiostrongylosis Image Figure 16. Schistosomiasis Image Figure 17. Other Image Figure 18. Global Antihelminthics Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 19. Global Antihelminthics Revenue (2021-2032) & (US$ Million) Figure 20. Global Antihelminthics Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 21. Global Antihelminthics Revenue Market Share by Region: 2025 Versus 2032 Figure 22. Global Antihelminthics Revenue Market Share by Region (2021-2032) Figure 23. Global Antihelminthics Sales (2021-2032) & (K Units) Figure 24. Global Antihelminthics Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 25. Global Antihelminthics Sales Market Share by Region (2021-2032) Figure 26. US & Canada & Mexico Antihelminthics Sales YoY (2021-2032) & (K Units) Figure 27. Europe Antihelminthics Sales YoY (2021-2032) & (K Units) Figure 28. China Antihelminthics Sales YoY (2021-2032) & (K Units) Figure 29. Asia (Excluding China) Antihelminthics Sales YoY (2021-2032) & (K Units) Figure 30. South America, Middle East and Africa Antihelminthics Sales YoY (2021-2032) & (K Units) Figure 31. Global Antihelminthics Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 32. Global Antihelminthics Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 33. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 34. Global Antihelminthics Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 35. Global Antihelminthics Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 36. Global Antihelminthics Revenue Market Share by Type (2021-2032) Figure 37. Global Antihelminthics Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 38. Global Antihelminthics Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 39. Global Antihelminthics Sales Market Share by Type (2021-2032) Figure 40. Global Antihelminthics Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 41. Global Antihelminthics Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 42. Global Antihelminthics Revenue Market Share by Application (2021-2032) Figure 43. Global Antihelminthics Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 44. Global Antihelminthics Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 45. Global Antihelminthics Sales Market Share by Application (2021-2032) Figure 46. North America Antihelminthics Revenue Share by Type (2021-2032) Figure 47. North America Antihelminthics Sales Share by Type (2021-2032) Figure 48. North America Antihelminthics Revenue Share by Application (2021-2032) Figure 49. North America Antihelminthics Sales Share by Application (2021-2032) Figure 50. North America Antihelminthics Revenue Share by Country (2021-2032) Figure 51. North America Antihelminthics Sales Share by Country (2021-2032) Figure 52. Europe Antihelminthics Revenue Share by Type (2021-2032) Figure 53. Europe Antihelminthics Sales Share by Type (2021-2032) Figure 54. Europe Antihelminthics Revenue Share by Application (2021-2032) Figure 55. Europe Antihelminthics Sales Share by Application (2021-2032) Figure 56. Europe Antihelminthics Revenue Share by Country (2021-2032) Figure 57. Europe Antihelminthics Sales Share by Country (2021-2032) Figure 58. China Antihelminthics Revenue Share by Type (2021-2032) Figure 59. China Antihelminthics Sales Share by Type (2021-2032) Figure 60. China Antihelminthics Revenue Share by Application (2021-2032) Figure 61. China Antihelminthics Sales Share by Application (2021-2032) Figure 62. Asia Antihelminthics Revenue Share by Type (2021-2032) Figure 63. Asia Antihelminthics Sales Share by Type (2021-2032) Figure 64. Asia Antihelminthics Revenue Share by Application (2021-2032) Figure 65. Asia Antihelminthics Sales Share by Application (2021-2032) Figure 66. Asia Antihelminthics Revenue Share by Country (2021-2032) Figure 67. Asia Antihelminthics Sales Share by Country (2021-2032) Figure 68. SAMEA Antihelminthics Revenue Share by Type (2021-2032) Figure 69. SAMEA Antihelminthics Sales Share by Type (2021-2032) Figure 70. SAMEA Antihelminthics Revenue Share by Application (2021-2032) Figure 71. SAMEA Antihelminthics Sales Share by Application (2021-2032) Figure 72. SAMEA Antihelminthics Revenue Share by Country (2021-2032) Figure 73. SAMEA Antihelminthics Sales Share by Country (2021-2032) Figure 74. Antihelminthics Value Chain Figure 75. Manufacturing Cost Structure Figure 76. Antihelminthics Production Mode & Process Figure 77. Direct Comparison with Distribution Share Figure 78. Distributors Profiles Figure 79. Years Considered Figure 80. Research Process Figure 81. Key Executives Interviewed

Scope & coverage.

Types
  • Salicylanilides
  • Benzimidazoles
  • Praziquantel
  • Abamectin
  • Other
Applications
  • Ascariasis
  • Giardiasis
  • Fasciolasis
  • Filariasis
  • Angiostrongylosis
  • Schistosomiasis
  • Other
Companies covered
  • Abbott
  • Sanofi
  • Sanofi
  • Johnson & Johnson
  • Novartis
  • Pfizer
  • GlaxoSmithKline
  • Bayer
  • AstraZeneca
  • ZEISS International
  • Merck & Co.
  • Mentis Pharma
  • Astellas Pharma
  • ALLERGAN

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Antihelminthics Market by Type
  3. 1.2.1 Global Antihelminthics Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Salicylanilides
  5. 1.2.3 Benzimidazoles
  6. 1.2.4 Praziquantel
  7. 1.2.5 Abamectin
  8. 1.2.6 Other
  9. 1.3 Antihelminthics Market by Application
  10. 1.3.1 Global Antihelminthics Market Size by Application, 2021 VS 2025 VS 2032
  11. 1.3.2 Ascariasis
  12. 1.3.3 Giardiasis
  13. 1.3.4 Fasciolasis
  14. 1.3.5 Filariasis
  15. 1.3.6 Angiostrongylosis
  16. 1.3.7 Schistosomiasis
  17. 1.3.8 Other
  18. 1.4 Assumptions and Limitations
  19. 1.5 Study Goals and Objectives
2 Antihelminthics Market Dynamics
  1. 2.1 Antihelminthics Industry Trends
  2. 2.2 Antihelminthics Industry Drivers
  3. 2.3 Antihelminthics Industry Opportunities and Challenges
  4. 2.4 Antihelminthics Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Antihelminthics Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Antihelminthics Revenue by Region
  3. 3.2.1 Global Antihelminthics Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Antihelminthics Revenue by Region (2021-2026)
  5. 3.2.3 Global Antihelminthics Revenue by Region (2027-2032)
  6. 3.2.4 Global Antihelminthics Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Antihelminthics Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Antihelminthics Sales by Region
  9. 3.4.1 Global Antihelminthics Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Antihelminthics Sales by Region (2021-2026)
  11. 3.4.3 Global Antihelminthics Sales by Region (2027-2032)
  12. 3.4.4 Global Antihelminthics Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Antihelminthics Revenue by Manufacturers
  2. 4.1.1 Global Antihelminthics Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Antihelminthics Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Antihelminthics Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Antihelminthics Sales by Manufacturers
  6. 4.2.1 Global Antihelminthics Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Antihelminthics Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Antihelminthics Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Antihelminthics Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Antihelminthics Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Antihelminthics Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Antihelminthics Manufacturers, Product Type & Application
  13. 4.7 Global Antihelminthics Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Antihelminthics Market CR5 and HHI
  16. 4.8.2 2025 Antihelminthics Tier 1, Tier 2, and Tier 3
5 Antihelminthics Market by Type
  1. 5.1 Global Antihelminthics Revenue by Type
  2. 5.1.1 Global Antihelminthics Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Antihelminthics Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Antihelminthics Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Antihelminthics Sales by Type
  6. 5.2.1 Global Antihelminthics Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Antihelminthics Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Antihelminthics Sales Market Share by Type (2021-2032)
  9. 5.3 Global Antihelminthics Price by Type
6 Antihelminthics Market by Application
  1. 6.1 Global Antihelminthics Revenue by Application
  2. 6.1.1 Global Antihelminthics Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Antihelminthics Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Antihelminthics Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Antihelminthics Sales by Application
  6. 6.2.1 Global Antihelminthics Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Antihelminthics Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Antihelminthics Sales Market Share by Application (2021-2032)
  9. 6.3 Global Antihelminthics Price by Application
7 Company Profiles
  1. 7.1 Abbott
  2. 7.1.1 Abbott Company Information
  3. 7.1.2 Abbott Business Overview
  4. 7.1.3 Abbott Antihelminthics Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Abbott Antihelminthics Product Portfolio
  6. 7.1.5 Abbott Recent Developments
  7. 7.2 Sanofi
  8. 7.2.1 Sanofi Company Information
  9. 7.2.2 Sanofi Business Overview
  10. 7.2.3 Sanofi Antihelminthics Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Sanofi Antihelminthics Product Portfolio
  12. 7.2.5 Sanofi Recent Developments
  13. 7.3 Sanofi
  14. 7.3.1 Sanofi Company Information
  15. 7.3.2 Sanofi Business Overview
  16. 7.3.3 Sanofi Antihelminthics Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Sanofi Antihelminthics Product Portfolio
  18. 7.3.5 Sanofi Recent Developments
  19. 7.4 Johnson & Johnson
  20. 7.4.1 Johnson & Johnson Company Information
  21. 7.4.2 Johnson & Johnson Business Overview
  22. 7.4.3 Johnson & Johnson Antihelminthics Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Johnson & Johnson Antihelminthics Product Portfolio
  24. 7.4.5 Johnson & Johnson Recent Developments
  25. 7.5 Novartis
  26. 7.5.1 Novartis Company Information
  27. 7.5.2 Novartis Business Overview
  28. 7.5.3 Novartis Antihelminthics Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Novartis Antihelminthics Product Portfolio
  30. 7.5.5 Novartis Recent Developments
  31. 7.6 Pfizer
  32. 7.6.1 Pfizer Company Information
  33. 7.6.2 Pfizer Business Overview
  34. 7.6.3 Pfizer Antihelminthics Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Pfizer Antihelminthics Product Portfolio
  36. 7.6.5 Pfizer Recent Developments
  37. 7.7 GlaxoSmithKline
  38. 7.7.1 GlaxoSmithKline Company Information
  39. 7.7.2 GlaxoSmithKline Business Overview
  40. 7.7.3 GlaxoSmithKline Antihelminthics Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 GlaxoSmithKline Antihelminthics Product Portfolio
  42. 7.7.5 GlaxoSmithKline Recent Developments
  43. 7.8 Bayer
  44. 7.8.1 Bayer Company Information
  45. 7.8.2 Bayer Business Overview
  46. 7.8.3 Bayer Antihelminthics Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Bayer Antihelminthics Product Portfolio
  48. 7.8.5 Bayer Recent Developments
  49. 7.9 AstraZeneca
  50. 7.9.1 AstraZeneca Company Information
  51. 7.9.2 AstraZeneca Business Overview
  52. 7.9.3 AstraZeneca Antihelminthics Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 AstraZeneca Antihelminthics Product Portfolio
  54. 7.9.5 AstraZeneca Recent Developments
  55. 7.10 ZEISS International
  56. 7.10.1 ZEISS International Company Information
  57. 7.10.2 ZEISS International Business Overview
  58. 7.10.3 ZEISS International Antihelminthics Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 ZEISS International Antihelminthics Product Portfolio
  60. 7.10.5 ZEISS International Recent Developments
  61. 7.11 Merck & Co.
  62. 7.11.1 Merck & Co. Company Information
  63. 7.11.2 Merck & Co. Business Overview
  64. 7.11.3 Merck & Co. Antihelminthics Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Merck & Co. Antihelminthics Product Portfolio
  66. 7.11.5 Merck & Co. Recent Developments
  67. 7.12 Mentis Pharma
  68. 7.12.1 Mentis Pharma Company Information
  69. 7.12.2 Mentis Pharma Business Overview
  70. 7.12.3 Mentis Pharma Antihelminthics Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Mentis Pharma Antihelminthics Product Portfolio
  72. 7.12.5 Mentis Pharma Recent Developments
  73. 7.13 Astellas Pharma
  74. 7.13.1 Astellas Pharma Company Information
  75. 7.13.2 Astellas Pharma Business Overview
  76. 7.13.3 Astellas Pharma Antihelminthics Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Astellas Pharma Antihelminthics Product Portfolio
  78. 7.13.5 Astellas Pharma Recent Developments
  79. 7.14 ALLERGAN
  80. 7.14.1 ALLERGAN Company Information
  81. 7.14.2 ALLERGAN Business Overview
  82. 7.14.3 ALLERGAN Antihelminthics Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 ALLERGAN Antihelminthics Product Portfolio
  84. 7.14.5 ALLERGAN Recent Developments
8 North America
  1. 8.1 North America Antihelminthics Market Size by Type
  2. 8.1.1 North America Antihelminthics Revenue by Type (2021-2032)
  3. 8.1.2 North America Antihelminthics Sales by Type (2021-2032)
  4. 8.1.3 North America Antihelminthics Price by Type (2021-2032)
  5. 8.2 North America Antihelminthics Market Size by Application
  6. 8.2.1 North America Antihelminthics Revenue by Application (2021-2032)
  7. 8.2.2 North America Antihelminthics Sales by Application (2021-2032)
  8. 8.2.3 North America Antihelminthics Price by Application (2021-2032)
  9. 8.3 North America Antihelminthics Market Size by Country
  10. 8.3.1 North America Antihelminthics Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Antihelminthics Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Antihelminthics Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Antihelminthics Market Size by Type
  2. 9.1.1 Europe Antihelminthics Revenue by Type (2021-2032)
  3. 9.1.2 Europe Antihelminthics Sales by Type (2021-2032)
  4. 9.1.3 Europe Antihelminthics Price by Type (2021-2032)
  5. 9.2 Europe Antihelminthics Market Size by Application
  6. 9.2.1 Europe Antihelminthics Revenue by Application (2021-2032)
  7. 9.2.2 Europe Antihelminthics Sales by Application (2021-2032)
  8. 9.2.3 Europe Antihelminthics Price by Application (2021-2032)
  9. 9.3 Europe Antihelminthics Market Size by Country
  10. 9.3.1 Europe Antihelminthics Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Antihelminthics Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Antihelminthics Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
  18. 9.3.9 Nordic Countries
10 China
  1. 10.1 China Antihelminthics Market Size by Type
  2. 10.1.1 China Antihelminthics Revenue by Type (2021-2032)
  3. 10.1.2 China Antihelminthics Sales by Type (2021-2032)
  4. 10.1.3 China Antihelminthics Price by Type (2021-2032)
  5. 10.2 China Antihelminthics Market Size by Application
  6. 10.2.1 China Antihelminthics Revenue by Application (2021-2032)
  7. 10.2.2 China Antihelminthics Sales by Application (2021-2032)
  8. 10.2.3 China Antihelminthics Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Antihelminthics Market Size by Type
  2. 11.1.1 Asia Antihelminthics Revenue by Type (2021-2032)
  3. 11.1.2 Asia Antihelminthics Sales by Type (2021-2032)
  4. 11.1.3 Asia Antihelminthics Price by Type (2021-2032)
  5. 11.2 Asia Antihelminthics Market Size by Application
  6. 11.2.1 Asia Antihelminthics Revenue by Application (2021-2032)
  7. 11.2.2 Asia Antihelminthics Sales by Application (2021-2032)
  8. 11.2.3 Asia Antihelminthics Price by Application (2021-2032)
  9. 11.3 Asia Antihelminthics Market Size by Country
  10. 11.3.1 Asia Antihelminthics Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Antihelminthics Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Antihelminthics Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Antihelminthics Market Size by Type
  2. 12.1.1 SAMEA Antihelminthics Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Antihelminthics Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Antihelminthics Price by Type (2021-2032)
  5. 12.2 SAMEA Antihelminthics Market Size by Application
  6. 12.2.1 SAMEA Antihelminthics Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Antihelminthics Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Antihelminthics Price by Application (2021-2032)
  9. 12.3 SAMEA Antihelminthics Market Size by Country
  10. 12.3.1 SAMEA Antihelminthics Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Antihelminthics Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Antihelminthics Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Antihelminthics Value Chain Analysis
  2. 13.1.1 Antihelminthics Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Antihelminthics Production Mode & Process
  6. 13.2 Antihelminthics Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Antihelminthics Distributors
  9. 13.2.3 Antihelminthics Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research